Narrative review / 2010
Methodological issues may contribute to conflicting findings regarding enterolactone and breast cancer risk in observational studies.
This review evaluates epidemiological studies examining blood or urine enterolactone, a biomarker of plant lignan exposure, and breast cancer risk. Case-control studies have reported decreased breast cancer risk linked to high circulating enterolactone levels, whereas prospective cohort findings are less clear. Potential contributors to these contradictory findings include age distribution, measurement errors, breast cancer subtype heterogeneity, genetic factors, and varying precursor sources. The authors conclude that addressing methodological problems and effect modifiers is needed to obtain robust evidence.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Human epidemiological studies (case-control and prospective cohorts)
- What was measured
- Enterolactone concentrations and breast cancer risk
THE PAPER
Enterolactone and breast cancer: methodological issues may contribute to conflicting results in observational studies.
Sonestedt E, Wirfält E. Nutr Res, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.